Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy

Abstract

This large matched-cohort study based on real-world data suggests that women receiving transdermal ET have significantly lower incidences of CVD events compared with those receiving oral ET, and that they also incur lower healthcare costs.